🔗 Share this article

A shadow market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.

Investigational Treatment Acquiring Popularity Via Social Media

Retatrutide, which remains in research studies, is being advertised by online personalities for its alleged fat-burning effects. Followers are encouraged to message these profiles directly for source information, while also obtaining discount codes.

Active Trade on Social Networks

Separately, a robust market exists on Telegram, where groups with thousands of participants share comparison images, injection guides and assertions of next-day British shipping. Sellers market the drug there before directing buyers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an investigational injectable created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Experts Express Concerns

Nevertheless, physicians and pharmacists have cautions that the distribution of what is still an unapproved medication in the United Kingdom is worrisome and could result in individuals injecting substances of unknown origin.

Some experts said the popularity for retatrutide could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Some content creators try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still breach medicines, marketing, and customer laws, potentially leading to penalties, prosecution or prison.

Service Reaction and Material Removal

Based on TikTok, the platform has taken down problematic content and prohibited associated hashtags and search suggestions. The organization said it was committed to keeping the platform secure and investing in strengthening compliance measures.

Online Trading Activities

Research also found groups with up to nine thousand participants selling retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of users, populated with photos of weight loss, glowing testimonials and detailed instructions for preparing or administering at residence.

After minutes of joining one community, a vendor shared WhatsApp details, where the majority of transactions occur. The vendor provided an guidebook and guaranteed shipping within two days. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about weight, medical conditions or previous experience.

Item Information and Pricing

Inside these communities, messages show black plastic packages with Royal Mail labels, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at residence with sterile water, or ready-to-use pens usually priced at 160 pounds for 20 milligrams. When asked how much time a injector should last, vendors give contradictory answers ranging from a several days to “depends on your body”.

Platform Moderation and Safety Measures

A representative for Telegram said it regularly monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are administering substances they cannot confirm. Even if the research behind this drug is sound, these digital versions may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to recent cost increases for authorized slimming medications such as Mounjaro. “With prices rising, individuals are turning to social media. But fake injections are extremely dangerous. You cannot know what’s contained or whether the conditions they were made in was clean,” she explained.

Her staff has already encountered individuals harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These materials could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly said the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they said, adding that any item “falsely representing itself as a company investigational product not yet authorized … may expose patients to potentially significant health risks”.